Favrille Financial Statements
Favrille Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Favrille Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (46.1) | (42.2) | (36.4) |
| Total Net Income ($ mil.) | (43.1) | (40.5) | (35.9) |
| Diluted EPS (Net Income) | (1.28) | (1.49) | (1.99) |
Favrille Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (41.6) | (10.6) | (10.2) |
| Total Net Income ($ mil.) | (39.4) | (10.5) | (7.8) |
| Diluted EPS (Net Income) | (0.96) | (0.25) | (0.18) |
Favrille Stock Quote & Chart
10/14/08 13:02:05 EST •
NASDAQ OTC BB •
0.01
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Favrille Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.25 | 1.44 |
| Price/Earnings Ratio | -- | 14.04 | 14.91 |
| Price/Book Ratio | -- | 2.53 | 1.40 |
| Price/Cash Flow Ratio | -- | 12.10 | 9.01 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Favrille Financial Ratios
Favrille Competitive Intelligence
| Accentia | Biogen Idec | Genitope | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18.3 | 3,171.6 | 0.0 |
| Employees | 140 | 4,300 | 206 |
| Market Cap ($ mil.) | 24.3 | 13,522.9 | -- |
Competitive Landscape
